PALM BEACH, Florida, June 25, 2019 /PRNewswire/ -- CBD just got another major shot in the arm. Just days ago, Kroger announced it would sell CBD products in nearly 1,000 stores. While it won't sell CBD-infused groceries yet, it will carry CBD topical products, including creams, balms and oils in 945 stores across 17 states. The company joins a growing list of other retailers that are just now jumping on the bandwagon. Simon Property Group partnered with Green Growth Brands. CVS will now carry CBD products across the U.S. The Vitamin Shoppe announced it will sell CBD products. Abercrombie & Fitch just partnered with Green Growth Brands to sell CBD body care products. In addition, analysts at Jefferies estimate the CBD beauty market will reach $25 billion over the next 10 years. That's opening a wide range of opportunity for companies including The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF), CV Sciences Inc. (OTCQB:CVSI), Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB), CannTrust Holdings Inc. (NYSE:CTST)(TSX:TRST), and Canopy Rivers Inc. (TSX-V:RIV)(OTCPK:CNPOF).
The Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) BREAKING NEWS: The Yield Growth Corp. just announced the following products containing hemp and other botanicals have completed stability and preservative challenge tests at a laboratory in British Columbia: eye cream, deodorant, Micellar Water Facial Cleanser in a bottle, Micellar Water Facial Cleanser in a jar with cotton pads, Roll on Facial Oil for All Skin Types, Roll on Facial Oil for Oily Skin, Face Mask for All Skin Types, Face Mask for Oily Skin, and Face Mask for Dry Skin. Yield Growth is currently in the market with hemp-based skin care products through Urban Juve and has plans to launch several CBD brands in California within the next 4 months. Additional tests will be completed on products with CBD in California. The company also has THC topical products approved for sale on Oregon.
"I am pleased with the accomplishments of our talented product development team that will enable us to launch full lines of CBD products in the US for first mover advantage," says Penny Green, Yield Growth CEO. "Our catalogue of high quality, unique formulas for CBD infusion supports our launch of new products for our CBD brands and also allows us to build additional revenues and assets through our licensing strategy. As this industry grows to $25 billion, we intend to be a dominant player." For more information on BOSS, please visit: https://yieldgrowth.com/
Other cannabis-related developments from around the markets include:
CV Sciences Inc. (OTCQB:CVSI) just announced further expansion of its industry-dominating Plus CBD Oil brand with The Kroger Co. The Company's expanded retail distribution includes the launch of CV Sciences' new PlusCBD OilRoll-Ons in 945 Kroger stores across many of its retail banners, including Kroger, Dillons, Fry's, Fred Meyer, King Sooper, Mariano's, Pick 'n Save, QFC and Smiths locations in 17 U.S. states. As discussed on the Company's first quarter 2019 earnings call on May 8, 2019, CV Sciences' recent distribution gains include availability of PlusCBD Oil Extra Strength Balm in an initial launch at CVS Pharmacy stores. With the addition of 945 Kroger locations and new distribution into other leading Food, Drug and Mass (FDM) retailers, as of June 12, 2019, PlusCBD Oil branded products are available in 4,591 retail stores, up from 3,308 retail stores as of March 31, 2019, an increase of 38.7% over the prior two months.
"We are delighted to partner with Kroger and launch our new Roll-On topical as we continue our rapid expansion into the FDM channel," said Joseph Dowling, CEO. "Kroger, CVS Pharmacy, and other leading national retailers are keenly aware of the increased consumer demand for hemp-based CBD products and they are partnering with CV Sciences because of our unwavering commitment to safety and quality. We are at the beginning of what we believe will be broad acceptance of CBD products across national FDM accounts and we look forward to our continued growth as we expand store count and SKUs with our retail partners."
Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB) announced its plans for the highly-anticipated expansion of the consumer cannabis market into vapes, concentrates, and edibles. The Company is also preparing to launch a national public awareness campaign this fall, educating consumers, provinces and retailers about the safe usage and consumption of these new derivative products. Through a combination of new and enhanced facilities, Aurora intends to produce new, high-quality products across the country in a variety of product categories. Aurora recently entered into a supply agreement with PAX Labs Inc., a leading consumer technology brand in cannabis. With the PAX partnership, the Company will have the market leading PAX Era device to compete in the Closed Loop category and will also launch a new range of vape products, at various price points, targeted to all major consumer markets through both 510 thread cartridges and disposable single-use units.
"Aurora is the world's leading producer of high-quality cannabis and we're ready to introduce high-value product additions to this improved, federally legal market," said the Company's CEO Terry Booth. "From the beginning, we've invested in industry-leading production and distribution technology, and in consumer research to drive products to market that consumers will desire. These things, together with the dynamic partnerships we've entered into on the accessory and technology fronts, position us well for this new market launch in December as per Health Canada's recent regulatory amendments."
CannTrust Holdings Inc. (NYSE:CTST)(TSX:TRST) announced that it is establishing operations in the United States starting in the State of California. CannTrust has signed a non-binding letter of intent that will provide access to over 3,000 acres of farmland for hemp production with Elk Grove Farming Company, LLC, a diversified farming company with operations in the State of California, to secure low-cost hemp with high cannabidiol content. CannTrust and Elk Grove will each have 50% ownership of a new entity. The opportunity in the U.S. for CannTrust is to become a trusted supplier of consistent, standardized and high-quality hemp-derived CBD formulations at scale. The Company believes there will be increasing demand for hemp-derived CBD formulations from international retailers and product manufacturers, and those organizations require expertise in genetics and value-add processing to ensure products are desirable and meet the highest safety standards.
Canopy Rivers Inc. (TSX-V:RIV)(OTCPK:CNPOF) just announced an investment and strategic collaboration between Canopy Rivers and ZeaKal, a California-based plant science innovator with proprietary technologies that sustainably increase photosynthesis, improve plant yield and enhance nutritional profiles for a variety of agricultural crops. The investment from Canopy Rivers marks another significant corporate milestone this calendar year for ZeaKal, following the February announcement of its R&D collaboration with Corteva Agriscience (NYSE: CTVA), the recently spun-out and NYSE-listed agricultural science division of DowDuPont. ZeaKal's proprietary technology, PhotoSeed, increases a plant's intrinsic photosynthetic capacity, meaning that PhotoSeed™ plants can convert more sunlight and carbon dioxide into energy for growth. This results in substantial improvement in seed and grain yield, as well as improved macronutrient profiles that drive an increase in both oil and protein content. For farmers, this means better productivity and profit margins; for consumers, this means higher nutritional profiles and an environmentally friendly way to meet growing global demand. With multi-year field trials across diverse plant species in the United States, Canada and New Zealand, the initial commercial focus has been on major row crops. Following Canopy Rivers' investment, ZeaKal intends to expand its program to include cannabis and hemp.
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third- party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM expects to be compensated twenty-five hundred dollars for news coverage of the current press release issued by The Yield Growth Corp. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.